FindTrial
Sign In

-

- - VT-1201

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
EU CTR
Registry ID
EUCTR2013-000142-19-ES
Enrollment
Unknown
Registered
2013-03-06
Start date
2013-05-31
Completion date
Unknown
Last updated
2013-07-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Trade Name: XALATAN Pharmaceutical Form: Eye drops, solution Trade Name: Xalatan Product Name: Latanoprost Product Code: - Pharmaceutical Form: Eye drops, solution in single-dose container INN or Pro

Sponsors

VISIOTACT PHARMA
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: - Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range 74 F.1.3 Elderly (>=65 years) yes F.1.3.1 Number of subjects for this age range 74

Exclusion criteria

Exclusion criteria: -

Design outcomes

Primary

MeasureTime frame
Main Objective: -;Secondary Objective: -;Primary end point(s): -;Timepoint(s) of evaluation of this end point: -—

Secondary

MeasureTime frame
Secondary end point(s): -;Timepoint(s) of evaluation of this end point: -—

Countries

Spain

Contacts

Public ContactArancha Maciá

Experior

macia.arancha@experior.es0034902105255

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026